Lonza | LONN - Operating Expenses



Lonza reported CHF3.09B in Operating Expenses for its fiscal semester ending in December of 2024.


Operating Expenses Change Date
Akzo Nobel EUR 2.32B 98M Jun/2025
Alcon AG USD 2.35B 344M Jun/2025
Almirall EUR 517.43M 265.53M Jun/2025
AstraZeneca USD 10.95B 1.04B Jun/2025
BASF EUR 14.94B 1.26B Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Beiersdorf EUR 4.37B 143M Jun/2025
Covestro EUR 3.33B 244M Jun/2025
Demant DKK 9.39B 392M Jun/2025
Fresenius EUR 5.02B 57M Jun/2025
Fresenius Medical Care EUR 4.36B 189M Jun/2025
Geberit CHF 640.8M 77.7M Mar/2025
Genmab DKK 565M 38M Jun/2025
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 5.96B 663M Jun/2025
GN Store Nord DKK 3.7B 72M Jun/2025
Hikma Pharmaceutical USD 1.31B 63M Dec/2024
Johnson Matthey GBP 6.08B 1.02B Mar/2025
Merck EUR 4.22B 49M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Philips EUR 3.85B 93M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Sanofi EUR 9.02B 702M Jun/2025
Sika AG CHF 2.5B 2.5B Jun/2024
Smith & Nephew USD 2.52B 133M Jun/2025
Solvay EUR 1.09B 4M Jun/2025
UCB EUR 2.36B 108M Dec/2024